Epigallocatechin gallate inhibits HBV DNA synthesis in a viral replication - inducible cell line

Figure 4 Epigallocatechin gallate does not affect hepatitis B virus core promoter activity. Twelve hours after cotransfection with pHBVCP-Luc and pRL-TK, HepG2.117 cells were treated with media containing different concentrations of Epigallocatechin gallate (EGCG) for 3 d, and were lysed for the dual luciferase reporter analysis. Core promoter activity was normalized with control TK promoter activity and presented as relative luciferase units. Error bars indicate standard deviation of 3 independent experiments.